logo

For the Inventor, By the Inventor

Birmingham, AL, United States of America

Robert D Elliott

This inventor holds 11 USPTO granted patents. Top assignees: Southern Research Institute, The Government of the United States of America, The United States of America. Active years: 1979-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert D Elliott. Retrieved from https://idiyas.com/inventor/robert-d-elliott

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 62(Granted Patents)


Company Filing History:

goldMedal9 out of 205 
 
Southern Research Institute
 patents
silverMedal1 out of 12 
 
The Government of the United States of America
 patents
bronzeMedal1 out of 255 
 
The United States of America
 patents

Years Active: 1979-1987

Loading Chart...
11 patents (USPTO):Explore Patents
1. 4645840 - Intermediates for preparing 1,2-dihydropyrido[3,4-b]-pyrazines (1987-02-24),
2. 4628089 - Pyrido(2,3-D)pyrimidines (1986-12-09),
3. 4600716 - 1,2-dihydropyrido[3,4-b]pyrazines (1986-07-15),
4. 4536575 - 2-Amino-4(3H)-oxopyrido[2,3-d]pyrimidino (1985-08-20),
5. 4526964 - 2,4-Diamino-6-(hydroxymethyl)pyrido[2,3-d]pyrimidine (1985-07-02),
6. 4511721 - Intermediate for preparing antifungal 1,2-dihydropyrido[3,4-b]-pyrazines (1985-04-16),
7. 4451650 - Pyrido[4,3-b][1,4]oxazines and pyrido[4,3-b][1,4]thiazines (1984-05-29),
8. 4450160 - 1,2-Dihydropyrido[3,4-b]-pyrazines and method and intermediates for (1984-05-22),
9. 4431805 - Pyrido[2,3-d]-pyrimidines (1984-02-14),
10. 4206307 - Preparation of tetrahydrofolic acid from folic acid (1980-06-03),
11. 4148999 - Preparation and purification of citrovorum factor (1979-04-10),

Title: **Robert D. Elliott: Innovator in Anticancer Compounds**

Introduction

Robert D. Elliott is a noteworthy inventor based in Birmingham, AL, recognized for his contributions to medicinal chemistry. With a prolific portfolio of 11 patents, his work primarily focuses on developing novel compounds with potential anticancer activities.

Latest Patents

Among his most recent patents, Robert has introduced groundbreaking intermediates for preparing 1,2-dihydropyrido[3,4-b]pyrazines, which exhibit significant anticancer properties. These compounds possess a unique structure characterized by several variables, including lower alkyl groups, halogens, and amine substitutions. Additionally, he has developed novel intermediates for pyrido[2,3-d]pyrimidines, further emphasizing his innovative approach to creating effective pharmaceutical agents.

Career Highlights

Throughout his career, Robert has worked with esteemed institutions that include the Southern Research Institute and the Government of the United States of America. His tenure at these organizations underscores his commitment to advancing medical research and innovation.

Collaborations

Robert has collaborated with distinguished coworkers such as Carroll G. Temple, Jr. and John A. Montgomery. These partnerships have played a vital role in fostering an environment of creativity and scientific advancement, which has driven numerous successful projects.

Conclusion

In summary, Robert D. Elliott's contributions to the field of medicinal chemistry are exemplified by his numerous patents and his dedication to developing innovative solutions for cancer treatment. His work not only reflects his ingenuity as an inventor but also his commitment to improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…